What is the recommended dosing of Clomid (clomiphene citrate) for men to increase testosterone levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clomiphene Citrate Dosing for Men to Increase Testosterone

For men seeking to increase testosterone levels, the recommended dosing of clomiphene citrate is 25 mg daily or 50 mg every other day, which has been shown to effectively raise testosterone levels while minimizing side effects. 1, 2

Mechanism and Indications

Clomiphene citrate (CC) is a selective estrogen receptor modulator (SERM) that works by:

  • Blocking estrogen receptors in the hypothalamus
  • Increasing luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release
  • Stimulating endogenous testosterone production

While not FDA-approved for men, CC is commonly prescribed off-label for:

  • Hypogonadism (low testosterone)
  • Preservation of fertility in men requiring testosterone therapy 3, 4

Dosing Protocol

Initial Dosing

  • Starting dose: 25 mg daily or 50 mg every other day 1, 2
  • Lower doses (25 mg three times weekly) may be effective in some men 5

Monitoring and Dose Adjustment

  • Check testosterone levels after 3 months of treatment
  • Target testosterone level: 450-600 ng/dL (mid-normal range) 4
  • Dose adjustment based on response:
    • If testosterone <350 ng/dL: Increase dose by 20-25%
    • If testosterone 350-750 ng/dL: Maintain current dose
    • If testosterone >750 ng/dL: Decrease dose by 20-25% 4

Expected Timeline of Effects

  1. Testosterone levels:

    • Significant improvement at 3 months (+62.7 ng/dL)
    • Additional benefit at 6 months (+181.8 ng/dL)
    • Plateau at 9-12 months 6
  2. Sperm parameters (if relevant):

    • First significant improvement in sperm concentration at 9 months 6

Efficacy and Outcomes

  • Mean testosterone increase: From ~300-350 ng/dL to ~600-650 ng/dL 1, 2
  • Clinical improvements:
    • Enhanced libido and sexual function
    • Improved energy levels
    • Better overall quality of life 1, 5
  • Long-term efficacy: Maintained for up to 7 years with continued treatment 2

Safety and Side Effects

Common side effects (generally mild):

  • Nipple tenderness (transient)
  • Visual disturbances (blurred vision)
  • Mood changes
  • Elevated estradiol levels 2

Important Considerations

  1. Fertility preservation: Unlike exogenous testosterone, CC preserves or may improve fertility, making it suitable for men who wish to maintain fertility 3, 4

  2. Duration of treatment:

    • For testosterone improvement: Minimum 3-6 months
    • For sperm parameter improvement: At least 9 months 6
  3. Monitoring recommendations:

    • Testosterone levels at 3,6, and 12 months
    • Hemoglobin/hematocrit to monitor for erythrocytosis
    • Lipid profile (CC may improve cholesterol levels) 1

Contraindications

  • Liver disease
  • History of thromboembolic events
  • Uncontrolled cardiovascular disease
  • Concurrent use of medications that may interact with CC

CC offers a viable alternative to traditional testosterone replacement therapy, particularly for men who wish to preserve fertility while addressing symptoms of low testosterone.

References

Research

Twenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency - a prospective study.

International braz j urol : official journal of the Brazilian Society of Urology, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Testosterone Replacement Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

CLOMIPHENE CITRATE IN THE TREATMENT OF IDIOPATHIC OR FUNCTIONAL HYPOGONADOTROPIC HYPOGONADISM IN MEN: A CASE SERIES AND REVIEW OF THE LITERATURE.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.